Dr. Davis leads one of the nation’s largest integrated health systems with eight hospitals, Icahn School of Medicine at Mount Sinai, Mount Sinai Phillips School of Nursing and over 400 ambulatory sites with annual revenue of $11.3 billion. In 2023, the system launched a $140 million behavioral health center, Center for Engineering and Precision Medicine and Center for Discovery and Innovation to serve as anchors for life-science and biotechnology development in lower Manhattan. Groundbreaking innovative, collaborative research ventures include launch of a company producing low-cost COVID-19 vaccine for developing countries and revolutionary advancements in clinical care including a nasal spray treatment for influenza and treatment resistant depression. As a neurobiologist, he conducted pioneering research that led the FDA to approve four of the first five drugs for treating Alzheimer’s disease. Honors include Yale University’s George H. W. Bush Lifetime of Leadership Award. Mount Sinai Health System is also among the first anti-racist healthcare and learning institutions with a Road Map of principles, strategies and supporting initiatives to create authentic and sustainable change.
